CLOVIS ONCOLOGY INC CLVS 2.5 09.15.21
NOTE 2.500% 9/1 · US DOMESTIC · CUSIP 189464AB6
14
institutional holders
2.0m
shares reported held*
$82.2mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $41.91.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. 1.37% of their portfolio | 49.1m $42.9m | — |
| Allianz Asset Management GmbH 0.03% of their portfolio | 33.3m $29.6m | — |
| FMR LLC 0.00% of their portfolio | 4.0m $3.5m | — |
| NOMURA HOLDINGS INC 0.00% of their portfolio | 4.0m $416.0k | — |
| PALISADE CAPITAL MANAGEMENT, LP 0.09% of their portfolio | 3.6m $3.2m | — |
| United Asset Strategies, Inc. 0.33% of their portfolio | 2.0m $1.7m | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 520.0k $442.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 169.0k $147.0k | — |
| MacKay Shields LLC 0.00% of their portfolio | 110.0k $96.0k | — |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 110.0k $98.7k | — |
| UBS Group AG 0.00% of their portfolio | 3.0k $3.0k | — |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.0k $1.0k | — |
| Advisor Group, Inc. 0.00% of their portfolio | 2 $2.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |